Conroy JM, et al. - The intent herein was to formulate a next-generation sequencing assay in order to illustrate a comprehensive characterization of the immunological tumor microenvironment as a guide for therapeutic decisions, with regard to patients with solid tumors. Such an assay was discovered to be highly reproducible and accurate than the established orthogonal approaches.